Phase III Randomized Study of Intraperitoneal AD 32 (N-Trifluoroacetyladriamycin-14-valerate) Versus Altretamine in Ovarian Cancer Patients Who Have Failed Platinum and Paclitaxel Chemotherapy

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date12/2/9612/31/99

    Funding

    • Anthra Pharmaceuticals, Inc. (Protocol #A9503)